←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Antisense Oligonucleotides
Jiang Yu
PhD
🏢Ionis Pharmaceuticals🌐USA
Senior Director of Research, Antisense Drug Discovery
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jiang Yu contributes to antisense oligonucleotide discovery and optimization at Ionis Pharmaceuticals including cancer targets. His work supports the preclinical pipeline of ASO oncology drugs. He has contributed to ASO screening methodologies and target validation.
Share:
🧪Research Fields 研究领域
ASO discovery
cancer oligonucleotide screening
RNA target validation
ASO potency optimization
oncogene ASO
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jiang Yu 的研究动态
Follow Jiang Yu's research updates
留下邮箱，当我们发布与 Jiang Yu（Ionis Pharmaceuticals）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment